Related Funds
| Fund Name | Location |
| Ardan Equity | Chicago, Illinois, United States |
| Berlin Metropolitan Ventures | Berlin, Berlin, Germany |
| BMO Capital Markets | Canada, Ontario, Toronto |
| CBC Group | Japan, Tokyo |
| China Yinhong | - |
| Dazu Venture Capital | China, Guangdong, Shenzhen |
| Element AI Capital | - |
| Infoteria Online | Japan, Tokyo |
| IoT Hub | - |
| Itochu Techno-Solutions | - |
| Jian Rong Ji Jin | China, Hebei, Hebei |
| Mercuria Investment | Chiyoda, Japan |
| Rochester Area Economic Development | Minnesota, Rochester, United States |
| Rubio Impact Ventures | Amsterdam, Noord-Holland, The Netherlands |
| Ruiying Touzi | China, Ürümqi, Xinjiang |
| Social Impact Finance | Bayern, Germany, München |
| Supernode | British Columbia, Canada, Vancouver |
| UniWill Ventures | California, Palo Alto, United States |
| White Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $11M | 03 Sep 2008 | San Francisco, California, United States | |||
Cytochroma | $16M | 18 Jan 2007 | Kingston, Ontario, Canada | ||
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
Ambit Biosciences | $31M | 12 May 2005 | San Diego, California, United States | ||
Xanthus Pharmaceuticals | $30M | 12 Dec 2003 | Cambridge, Massachusetts, United States | ||
LymphoSign | $5M | 03 Jul 2003 | Markham, Ontario, Canada | ||
Salmedix Inc | $27M | 19 Jun 2002 | San Diego, California, United States | ||
| $2M | 18 Dec 2001 | Ontario | |||
Cytochroma | $7M | 30 Oct 2001 | Ontario |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $11M | 03 Sep 2008 | San Francisco, California, United States | |||
Cytochroma | $16M | 18 Jan 2007 | Kingston, Ontario, Canada | ||
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
Ambit Biosciences | $31M | 12 May 2005 | San Diego, California, United States | ||
Xanthus Pharmaceuticals | $30M | 12 Dec 2003 | Cambridge, Massachusetts, United States | ||
LymphoSign | $5M | 03 Jul 2003 | Markham, Ontario, Canada | ||
Salmedix Inc | $27M | 19 Jun 2002 | San Diego, California, United States | ||
| $2M | 18 Dec 2001 | Ontario | |||
Cytochroma | $7M | 30 Oct 2001 | Ontario |
